about
Subverting Subversion: A Review on the Breast Cancer Microenvironment and Therapeutic OpportunitiesGene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.Common shared genetic variation behind decreased risk of breast cancer in celiac disease.Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patientsTherapeutic Touch Has Significant Effects on Mouse Breast Cancer Metastasis and Immune Responses but Not Primary Tumor Size.The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer.Beneficial bacteria inhibit cachexia.CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.Gut bacteria and cancerTAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer.Portraying breast cancers with long noncoding RNAs.A variety of gene polymorphisms associated with idiopathic granulomatous mastitisInflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast texturesHarnessing the immune system for the treatment of breast cancer.The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.Significance of interleukin-33 and its related cytokines in patients with breast cancers.Mechanism of immune evasion in breast cancer.Analysis of the intricate relationship between chronic inflammation and cancer.The immune system and cancer evasion strategies: therapeutic concepts.The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer.Estrogen, Estrogen Receptor and Lung CancerIdentifying and analyzing different cancer subtypes using RNA-seq data of blood platelets.Honey: A Therapeutic Agent for Disorders of the Skin.Repurposing Antiestrogens for Tumor Immunotherapy.Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.Association between inflammation and cancer stem cell phenotype in breast cancer.Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling.Immunotherapy for Breast Cancer: Current and Future Strategies.The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.Association of serum interleukin-10, interleukin-17A and transforming growth factor-α levels with human benign and malignant breast diseases.Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer.An isoform of AIF1 involved in breast cancer
P2860
Q26784839-88E66ED6-BCB4-4443-B98F-0FBF4CE422B9Q33591757-5F18CB1D-04FC-45C4-A337-3AE311106AB8Q33918347-255BEC6E-6FBA-4E9B-A77A-3B38DC6B211EQ35595696-C10D5C17-23D1-44E8-B7B5-0BCFB8B8DE30Q35737802-B9F99E92-049E-4E82-8500-5723F7811800Q36749454-F65B10F7-669E-4BB8-B77B-85EF33BA87C2Q37022010-7DA5CBFD-97E6-4D76-949A-1B0B8DAE5329Q37058153-AD7BE5D0-B0D2-4A0D-8E3E-0AA52CEF63CBQ37082877-7DD17AFC-B785-4463-873E-5B9F0D9BAC7AQ37225680-8672B0A4-FCF5-49EC-87CE-D9EDAD8B0E92Q37230214-0B3340DE-F68C-42F0-B057-E8402F6F34DAQ37248538-FA06987D-232A-4E84-8698-6192F3F0C4F5Q37448056-91E258BC-938E-405F-83C1-8121AE844A24Q37476039-B31D1472-2351-4E2E-9DAC-107664D1354DQ37571181-EDB9831C-F107-4E3B-AE28-A44DC483DC5AQ37593533-1A3F6A79-43E1-4960-8213-EAFB14979F83Q37660315-4202C959-F257-4641-91D7-0AFF5DE8EDCEQ37700227-50FFE7CD-BE4C-4206-82E1-C82F98627C7BQ37712385-E9EFA9E6-A209-46CA-8BE6-25250A4BD437Q38458724-65D26687-7512-4D3F-8FA1-4684D658D197Q38691172-B721323B-5A7B-472C-AB26-B74B50AC21DBQ39346175-7945518E-6CE9-41B5-8C1F-957940F717DAQ41520280-B410DEA8-C586-4C1A-B7A1-AEC52DEBE046Q41573792-58946873-9A7A-4DF8-959E-5F851AA4BD31Q45943794-391416EC-E0D8-4774-8D86-C40D0CD9DD21Q46406778-E450CD1D-8DCD-41F6-84EF-50D21A1CB117Q47148691-32295AF6-1D22-4C2B-B763-C82A308DBC65Q48113563-509FC550-9D95-43C9-B4CF-A8AFCEB6C0A8Q48284336-D74672C9-DB08-4C34-B870-B1673E71EC86Q49704531-30B702F9-B19B-403E-A7BD-823BDED532F2Q50700728-1A05CEB1-EF00-4BD7-885D-65D10E9BEB12Q52367069-5A94EA1A-D20F-4167-8230-082B123AA8E8Q52587066-CD5C489A-F46D-42DC-82D6-F31E934BE74EQ52874472-8CCCC6A8-2224-4B0E-A6FC-1017CB0435F5Q55361324-AC46DBD3-5871-4D32-A873-7D90E5AD0B9EQ55483878-EDF89EE2-B6DE-4821-9335-1DBEB44F25E9Q58579151-0ECCB69D-9D91-4942-850B-7515CD07D251
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The immune system and inflammation in breast cancer.
@en
The immune system and inflammation in breast cancer.
@nl
type
label
The immune system and inflammation in breast cancer.
@en
The immune system and inflammation in breast cancer.
@nl
prefLabel
The immune system and inflammation in breast cancer.
@en
The immune system and inflammation in breast cancer.
@nl
P2860
P1476
The immune system and inflammation in breast cancer.
@en
P2093
David J Shapiro
Xinguo Jiang
P2860
P304
P356
10.1016/J.MCE.2013.06.003
P577
2013-06-19T00:00:00Z